II 

110TH CONGRESS 

1ST SESSION S. 1687 

To provide for global pathogen surveillance and response. 

IN THE SENATE OF THE UNITED STATES 

JUNE 25, 2007 

Mr. BIDEN (for himself, Mr. HAGEL, Mr. KENNEDY, and Mr. CASEY) introduced the following bill; which was read twice and referred to the Committee on Foreign Relations 

A BILL 

To provide for global pathogen surveillance and response. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Global Pathogen Sur5 veillance Act of 2007’’. 

6 SEC. 2. FINDINGS; PURPOSE. 

7 (a) FINDINGS.—Congress makes the following find8 ings: 

9 (1) The frequency of the occurrence of biologi10 cal events that could threaten the national security 

11 of the United States has increased and is likely inVerDate Aug 31 2005 04:45 Jun 26, 2007 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\S1687.IS S1687

hmoore on PRODPC68 with HMBILLS
2 

•S 1687 IS

1 creasing. The threat to the United States from such 

2 events includes threats from diseases that infect hu3 mans, animals, or plants regardless of if such dis4 eases are introduced naturally, accidentally, or inten5 tionally. 

6 (2) The United States lacks an effective and 

7 real-time system to detect, identify, contain, and re8 spond to global threats and also lacks an effective 

9 mechanism to disseminate information to the na10 tional response community if such threats arise. 

11 (3) Bioterrorism poses a grave national security 

12 threat to the United States. The insidious nature of 

13 a bioterrorist attack, the likelihood that the recogni14 tion of such an attack would be delayed, and the 

15 underpreparedness of the domestic public health in16 frastructure to respond to such an attack could re17 sult in catastrophic consequences following a biologi18 cal weapons attack against the United States. 

19 (4) The ability to recognize that a country or 

20 organization is carrying out a covert biological weap21 ons programs is dependent on a number of indica22 tions and warnings. A critical component of this rec23 ognition is the timely detection of sentinel events 

24 such as laboratory accidents and community-level 

25 outbreaks that could be the earliest indication of an 


hmoore on PRODPC68 with HMBILLS
3 

•S 1687 IS

1 emerging bioterrorist program in a foreign country. 

2 Early detection of such events may enable earlier 

3 counterproliferation intervention. 

4 (5) A contagious pathogen engineered as a bio5 logical weapon and developed, tested, produced, or 

6 released in a foreign country could quickly spread to 

7 the United States. Considering the realities of inter8 national travel, trade, and migration patterns, a 

9 dangerous pathogen appearing naturally, acciden10 tally, or intentionally anywhere in the world can 

11 spread to the United States in a matter of days, be12 fore any effective quarantine or isolation measures 

13 could be implemented. 

14 (6) To combat bioterrorism effectively and en15 sure that the United States is fully prepared to pre16 vent, recognize, and contain a biological weapons at17 tack, or emerging infectious disease, measures to 

18 strengthen the domestic public health infrastructure 

19 and improve domestic event detection, surveillance, 

20 and response, while absolutely essential, are not suf21 ficient. 

22 (7) The United States should enhance coopera23 tion with the World Health Organization, regional 

24 international health organizations, and individual 

25 countries, including data sharing with appropriate 


hmoore on PRODPC68 with HMBILLS
4 

•S 1687 IS

1 agencies and departments of the United States, to 

2 help detect and quickly contain infectious disease 

3 outbreaks or a bioterrorism agent before such a dis4 ease or agent is spread. 

5 (8) The World Health Organization has done 

6 an impressive job in monitoring infectious disease 

7 outbreaks around the world, particularly with the es8 tablishment in April 2000 of the Global Outbreak 

9 Alert and Response Network. 

10 (9) The capabilities of the World Health Orga11 nization depend on the timeliness and quality of the 

12 data and information the Organization receives from 

13 the countries that are members of the Organization, 

14 pursuant to the 2005 revision of the International 

15 Health Regulations. Developing countries, in par16 ticular, often lack the necessary resources to build 

17 and maintain effective public health infrastructures. 

18 (10) In particular, developing countries could 

19 benefit from— 

20 (A) better trained public health profes21 sionals and epidemiologists to recognize disease 

22 patterns; 

23 (B) appropriate laboratory equipment for 

24 diagnosis of pathogens; 

25 (C) disease reporting systems that— 


hmoore on PRODPC68 with HMBILLS
5 

•S 1687 IS

1 (i) are based on disease and syndrome 

2 surveillance; and 

3 (ii) could enable an effective response 

4 to a biological event to begin at the earliest 

5 possible opportunity; 

6 (D) a narrowing of the existing technology 

7 gap in disease and syndrome surveillance capa8 bilities, based on reported symptoms, and real9 time information dissemination to public health 

10 officials; and 

11 (E) appropriate communications equip12 ment and information technology to efficiently 

13 transmit information and data within national, 

14 international regional, and international health 

15 networks, including inexpensive, Internet-based 

16 Geographic Information Systems (GIS) and rel17 evant telephone-based systems for early recogni18 tion and diagnosis of diseases. 

19 (11) An effective international capability to de20 tect, monitor, and quickly diagnose infectious disease 

21 outbreaks will offer dividends not only in the event 

22 of biological weapons development, testing, produc23 tion, and attack, but also in the more likely cases of 

24 naturally occurring infectious disease outbreaks that 

25 could threaten the United States. Furthermore, a 


hmoore on PRODPC68 with HMBILLS
6 

•S 1687 IS

1 robust surveillance system will serve to deter, pre2 vent, or contain terrorist use of biological weapons, 

3 mitigating the intended effects of such malevolent 

4 uses. 

5 (b) PURPOSES.—The purposes of this Act are as fol6 lows: 

7 (1) To provide the United States with an effec8 tive and real-time system to detect biological threats 

9 that— 

10 (A) utilizes classified and unclassified in11 formation to detect such threats; and 

12 (B) may be utilized by the human or the 

13 agricultural domestic disease response commu14 nity. 

15 (2) To enhance the capability of the inter16 national community, through the World Health Or17 ganization and individual countries, to detect, iden18 tify, and contain infectious disease outbreaks, wheth19 er the cause of those outbreaks is intentional human 

20 action or natural in origin. 

21 (3) To enhance the training of public health 

22 professionals and epidemiologists from eligible devel23 oping countries in advanced Internet-based disease 

24 and syndrome surveillance systems, in addition to 

25 traditional epidemiology methods, so that such proVerDate Aug 31 2005 04:45 Jun 26, 2007 Jkt 059200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\S1687.IS S1687

hmoore on PRODPC68 with HMBILLS
7 

•S 1687 IS

1 fessionals and epidemiologists may better detect, di2 agnose, and contain infectious disease outbreaks, es3 pecially such outbreaks caused by the pathogens that 

4 may be likely to be used in a biological weapons at5 tack. 

6 (4) To provide assistance to developing coun7 tries to purchase appropriate communications equip8 ment and information technology to detect, analyze, 

9 and report biological threats, including— 

10 (A) relevant computer equipment, Internet 

11 connectivity mechanisms, and telephone-based 

12 applications to effectively gather, analyze, and 

13 transmit public health information for infec14 tious disease surveillance and diagnosis; and 

15 (B) appropriate computer equipment and 

16 Internet connectivity mechanisms— 

17 (i) to facilitate the exchange of Geo18 graphic Information Systems-based disease 

19 and syndrome surveillance information; 

20 and 

21 (ii) to effectively gather, analyze, and 

22 transmit public health information for in23 fectious disease surveillance and diagnosis. 

24 (5) To make available greater numbers of pub25 lic health professionals who are employed by the 


hmoore on PRODPC68 with HMBILLS
8 

•S 1687 IS

1 Government of the United States to international re2 gional and international health organizations, inter3 national regional and international health networks, 

4 and United States diplomatic missions, as appro5 priate. 

6 (6) To expand the training and outreach activi7 ties of United States laboratories located in foreign 

8 countries, including the Centers for Disease Control 

9 and Prevention or Department of Defense labora10 tories, to enhance the public health capabilities of 

11 developing countries. 

12 (7) To provide appropriate technical assistance 

13 to existing international regional and international 

14 health networks and, as appropriate, seed money for 

15 new international regional and international net16 works. 

17 SEC. 3. DEFINITIONS. 

18 In this Act: 

19 (1) ELIGIBLE DEVELOPING COUNTRY.—The 

20 term ‘‘eligible developing country’’ means any devel21 oping country that— 

22 (A) has agreed to the objective of fully 

23 complying with requirements of the World 

24 Health Organization on reporting public health 

25 information on outbreaks of infectious diseases; 


hmoore on PRODPC68 with HMBILLS
9 

•S 1687 IS

1 (B) has not been determined by the Sec2 retary, for purposes of section 40 of the Arms 

3 Export Control Act (22 U.S.C. 2780), section 

4 620A of the Foreign Assistance Act of 1961 

5 (22 U.S.C. 2371), or section 6(j) of the Export 

6 Administration Act of 1979 (as in effect pursu7 ant to the International Emergency Economic 

8 Powers Act; 50 U.S.C. 1701 et seq.), to have 

9 repeatedly provided support for acts of inter10 national terrorism, unless the Secretary exer11 cises a waiver certifying that it is in the na12 tional interest of the United States to provide 

13 assistance under the provisions of this Act; and 

14 (C) is a party to the Convention on the 

15 Prohibition of the Development, Production and 

16 Stockpiling of Bacteriological (Biological) and 

17 Toxin Weapons and on Their Destruction, done 

18 at Washington, London, and Moscow April 10, 

19 1972 (26 UST 583). 

20 (2) ELIGIBLE NATIONAL.—The term ‘‘eligible 

21 national’’ means any citizen or national of an eligible 

22 developing country who— 

23 (A) does not have a criminal background; 

24 (B) is not on any immigration or other 

25 United States watch list; and 


hmoore on PRODPC68 with HMBILLS
10 

•S 1687 IS

1 (C) is not affiliated with any foreign ter2 rorist organization. 

3 (3) INTERNATIONAL HEALTH ORGANIZATION.— 

4 The term ‘‘international health organization’’ in5 cludes the World Health Organization, regional of6 fices of the World Health Organization, and inter7 national health organizations, such as the Pan 

8 American Health Organization. 

9 (4) LABORATORY.—The term ‘‘laboratory’’ 

10 means a facility for the biological, microbiological, 

11 serological, chemical, immuno-hematological, 

12 hematological, biophysical, cytological, pathological, 

13 or other medical examination of materials derived 

14 from the human body for the purpose of providing 

15 information for the diagnosis, prevention, or treat16 ment of any disease or impairment of, or the assess17 ment of the health of, human beings. 

18 (5) SECRETARY.—Unless otherwise provided, 

19 the term ‘‘Secretary’’ means the Secretary of State. 

20 (6) DISEASE AND SYNDROME SURVEILLANCE.— 

21 The term ‘‘disease and syndrome surveillance’’ 

22 means the recording of clinician-reported symptoms 

23 (patient complaints) and signs (derived from phys24 ical examination and laboratory data) combined with 


hmoore on PRODPC68 with HMBILLS
11 

•S 1687 IS

1 simple geographic locators to track the emergence of 

2 a disease in a population. 

3 SEC. 4. ELIGIBILITY FOR ASSISTANCE. 

4 (a) IN GENERAL.—Except as provided in subsection 

5 (b), assistance may be provided to an eligible developing 

6 country under any provision of this Act only if the govern7 ment of the eligible developing country— 

8 (1) permits personnel from the World Health 

9 Organization and the Centers for Disease Control 

10 and Prevention to investigate outbreaks of infectious 

11 diseases within the borders of such country; and 

12 (2) provides pathogen surveillance data to the 

13 appropriate agencies and departments of the United 

14 States and to international health organizations. 

15 (b) WAIVER.—The Secretary may waive the prohibi16 tion set out in subsection (a) if the Secretary determines 

17 that it is in the national interest of the United States to 

18 provide such a waiver. 

19 SEC. 5. RESTRICTION. 

20 (a) IN GENERAL.—Notwithstanding any other provi21 sion of this Act, no foreign national participating in a pro22 gram authorized under this Act shall have access, during 

23 the course of such participation, to a select agent or toxin 

24 described in section 73.4 of title 42, Code of Federal Reg25 ulations (or any corresponding similar regulation) or an 


hmoore on PRODPC68 with HMBILLS
12 

•S 1687 IS

1 overlap select agent or toxin described in section 73.5 of 

2 such title (or any corresponding similar regulation) that 

3 may be used as, or in, a biological weapon, except in a 

4 supervised and controlled setting. 

5 (b) RELATIONSHIP TO REGULATIONS.—The restric6 tion set out in subsection (a) may not be construed to limit 

7 the ability of the Secretary of Health and Human Services 

8 to prescribe, through regulation, standards for the han9 dling of a select agent or toxin or an overlap select agent 

10 or toxin described in such subsection. 

11 SEC. 6. FELLOWSHIP PROGRAM. 

12 (a) ESTABLISHMENT.—There is established a fellow13 ship program under which the Secretary, in consultation 

14 with the Secretary of Health and Human Services and 

15 subject to the availability of appropriations, shall award 

16 fellowships to eligible nationals to pursue public health 

17 education or training, as follows: 

18 (1) MASTER OF PUBLIC HEALTH DEGREE.— 

19 Graduate courses of study leading to a master of 

20 public health degree with a concentration in epidemi21 ology from an institution of higher education in the 

22 United States with a Center for Public Health Pre23 paredness, as determined by the Director of the Cen24 ters for Disease Control and Prevention. 


hmoore on PRODPC68 with HMBILLS
13 

•S 1687 IS

1 (2) ADVANCED PUBLIC HEALTH EPIDEMIOLOGY

2 TRAINING.—Advanced public health training in epi3 demiology for public health professionals from eligi4 ble developing countries to be carried out at the 

5 Centers for Disease Control and Prevention, an ap6 propriate facility of a State, or an appropriate facil7 ity of another agency or department of the United 

8 States (other than a facility of the Department of 

9 Defense or a national laboratory of the Department 

10 of Energy) for a period of not less than 6 months 

11 or more than 12 months. 

12 (b) SPECIALIZATION IN BIOTERRORISM.—In addition 

13 to the education or training specified in subsection (a), 

14 each recipient of a fellowship under this section (in this 

15 section referred to as a ‘‘fellow’’) may take courses of 

16 study at the Centers for Disease Control and Prevention 

17 or at an equivalent facility on diagnosis and containment 

18 of likely bioterrorism agents. 

19 (c) FELLOWSHIP AGREEMENT.— 

20 (1) IN GENERAL.—A fellow shall enter into an 

21 agreement with the Secretary under which the fellow 

22 agrees— 

23 (A) to maintain satisfactory academic 

24 progress, as determined in accordance with reg25 ulations issued by the Secretary and confirmed 


hmoore on PRODPC68 with HMBILLS
14 

•S 1687 IS

1 in regularly scheduled updates to the Secretary 

2 from the institution providing the education or 

3 training on the progress of the fellow’s edu4 cation or training; 

5 (B) upon completion of such education or 

6 training, to return to the fellow’s country of na7 tionality or last habitual residence (so long as 

8 it is an eligible developing country) and com9 plete at least 4 years of employment in a public 

10 health position in the government or a non11 governmental, not-for-profit entity in that coun12 try or, with the approval of the Secretary, com13 plete part or all of this requirement through 

14 service with an international health organiza15 tion without geographic restriction; and 

16 (C) that, if the fellow is unable to meet the 

17 requirements described in subparagraph (A) or 

18 (B), the fellow shall reimburse the United 

19 States for the value of the assistance provided 

20 to the fellow under the fellowship program, to21 gether with interest at a rate that— 

22 (i) is determined in accordance with 

23 regulations issued by the Secretary; and 


hmoore on PRODPC68 with HMBILLS
15 

•S 1687 IS

1 (ii) is not higher than the rate gen2 erally applied in connection with other 

3 Federal loans. 

4 (2) WAIVERS.—The Secretary may waive the 

5 application of subparagraph (B) or (C) of paragraph 

6 (1) if the Secretary determines that it is in the na7 tional interest of the United States to provide such 

8 a waiver. 

9 (d) AGREEMENT.—The Secretary, in consultation 

10 with the Secretary of Health and Human Services, is au11 thorized to enter into an agreement with the government 

12 of an eligible developing country under which such govern13 ment agrees— 

14 (1) to establish a procedure for the nomination 

15 of eligible nationals for fellowships under this sec16 tion; 

17 (2) to guarantee that a fellow will be offered a 

18 professional public health position within the devel19 oping country upon completion of the fellow’s stud20 ies; and 

21 (3) to submit to the Secretary a certification 

22 stating that a fellow has concluded the minimum pe23 riod of employment in a public health position re24 quired by the fellowship agreement, including an ex25 planation of how the requirement was met. 


hmoore on PRODPC68 with HMBILLS
16 

•S 1687 IS

1 (e) PARTICIPATION OF UNITED STATES CITIZENS.— 

2 On a case-by-case basis, the Secretary may provide for the 

3 participation of a citizen of the United States in the fel4 lowship program under the provisions of this section if— 

5 (1) the Secretary determines that it is in the 

6 national interest of the United States to provide for 

7 such participation; and 

8 (2) the citizen of the United States agrees to 

9 complete, at the conclusion of such participation, at 

10 least 5 years of employment in a public health posi11 tion in an eligible developing country or at an inter12 national health organization. 

13 (f) USE OF EXISTING PROGRAMS.—The Secretary, 

14 with the concurrence of the Secretary of Health and 

15 Human Services, may elect to use existing programs of 

16 the Department of Health and Human Services to provide 

17 the education and training described in subsection (a) if 

18 the requirements of subsections (b), (c), and (d) will be 

19 substantially met under such existing programs. 

20 SEC. 7. IN-COUNTRY TRAINING IN LABORATORY TECH21 NIQUES AND DISEASE AND SYNDROME SUR22 VEILLANCE. 

23 (a) LABORATORY TECHNIQUES.— 

24 (1) IN GENERAL.—The Secretary, after con25 sultation with the Secretary of Health and Human 


hmoore on PRODPC68 with HMBILLS
17 

•S 1687 IS

1 Services and the Secretary of Defense and in con2 junction with elements of those departments that en3 gage in activities of this type overseas, and subject 

4 to the availability of appropriations, shall provide as5 sistance for short training courses for eligible na6 tionals who are laboratory technicians or other pub7 lic health personnel in laboratory techniques relating 

8 to the identification, diagnosis, and tracking of 

9 pathogens responsible for possible infectious disease 

10 outbreaks. 

11 (2) LOCATION.—The training described in 

12 paragraph (1) shall be held outside the United 

13 States and may be conducted in facilities of the Cen14 ters for Disease Control and Prevention located in 

15 foreign countries or in Overseas Medical Research 

16 Units of the Department of Defense, as appropriate. 

17 (3) COORDINATION WITH EXISTING PRO18 GRAMS.—The Secretary shall coordinate the training 

19 described in paragraph (1), where appropriate, with 

20 existing programs and activities of international 

21 health organizations. 

22 (b) DISEASE AND SYNDROME SURVEILLANCE.— 

23 (1) IN GENERAL.—The Secretary, after con24 sultation with the Secretary of Health and Human 

25 Services and the Secretary of Defense and in conVerDate Aug 31 2005 04:45 Jun 26, 2007 Jkt 059200 PO 00000 Frm 00017 Fmt 6652 Sfmt 6201 E:\BILLS\S1687.IS S1687

hmoore on PRODPC68 with HMBILLS
18 

•S 1687 IS

1 junction with elements of those departments that en2 gage in activities of this type overseas, and subject 

3 to the availability of appropriations, shall establish 

4 and provide assistance for short training courses for 

5 eligible nationals who are health care providers or 

6 other public health personnel in techniques of dis7 ease and syndrome surveillance reporting and rapid 

8 analysis of syndrome information using Geographic 

9 Information System (GIS) tools. 

10 (2) LOCATION.—The training described in 

11 paragraph (1) shall be conducted via the Internet or 

12 in appropriate facilities located in a foreign country, 

13 as determined by the Secretary. 

14 (3) COORDINATION WITH EXISTING PRO15 GRAMS.—The Secretary shall coordinate the training 

16 described in paragraph (1), where appropriate, with 

17 existing programs and activities of international re18 gional and international health organizations. 

19 SEC. 8. ASSISTANCE FOR THE PURCHASE AND MAINTE20 NANCE OF PUBLIC HEALTH LABORATORY 

21 EQUIPMENT AND SUPPLIES. 

22 (a) AUTHORIZATION.—The President is authorized to 

23 provide, on such terms and conditions as the President 

24 may determine, assistance to eligible developing countries 


hmoore on PRODPC68 with HMBILLS
19 

•S 1687 IS

1 to purchase and maintain the public health laboratory 

2 equipment and supplies described in subsection (b). 

3 (b) EQUIPMENT AND SUPPLIES COVERED.—The 

4 equipment and supplies described in this subsection are 

5 equipment and supplies that are— 

6 (1) appropriate, to the extent possible, for use 

7 in the intended geographic area; 

8 (2) necessary to collect, analyze, and identify 

9 expeditiously a broad array of pathogens, including 

10 mutant strains, which may cause disease outbreaks 

11 or may be used in a biological weapon; 

12 (3) compatible with general standards set forth 

13 by the World Health Organization and, as appro14 priate, the Centers for Disease Control and Preven15 tion, to ensure interoperability with international re16 gional and international public health networks; and 

17 (4) not defense articles, defense services, or 

18 training, as such terms are defined in the Arms Ex19 port Control Act (22 U.S.C. 2751 et seq.). 

20 (c) RULE OF CONSTRUCTION.—Nothing in this sec21 tion shall be construed to exempt the exporting of goods 

22 and technology from compliance with applicable provisions 

23 of the Export Administration Act of 1979 (as in effect 

24 pursuant to the International Emergency Economic Pow25 ers Act; 50 U.S.C. 1701 et seq.). 


hmoore on PRODPC68 with HMBILLS
20 

•S 1687 IS

1 (d) LIMITATION.—Amounts appropriated to carry 

2 out this section shall not be made available for the pur3 chase from a foreign country of equipment or supplies 

4 that, if made in the United States, would be subject to 

5 the Arms Export Control Act (22 U.S.C. 2751 et seq.) 

6 or likely be barred or subject to special conditions under 

7 the Export Administration Act of 1979 (as in effect pursu8 ant to the International Emergency Economic Powers Act; 

9 50 U.S.C. 1701 et seq.). 

10 (e) PROCUREMENT PREFERENCE.—In the use of 

11 grant funds authorized under subsection (a), preference 

12 should be given to the purchase of equipment and supplies 

13 of United States manufacture. The use of amounts appro14 priated to carry out this section shall be subject to section 

15 604 of the Foreign Assistance Act of 1961 (22 U.S.C. 

16 2354). 

17 (f) COUNTRY COMMITMENTS.—The assistance pro18 vided under this section for equipment and supplies may 

19 be provided only if the eligible developing country that re20 ceives such equipment and supplies agrees to provide the 

21 infrastructure, technical personnel, and other resources re22 quired to house, maintain, support, secure, and maximize 

23 use of such equipment and supplies. 


hmoore on PRODPC68 with HMBILLS
21 

•S 1687 IS

1 SEC. 9. ASSISTANCE FOR IMPROVED COMMUNICATION OF 

2 PUBLIC HEALTH INFORMATION. 

3 (a) ASSISTANCE FOR PURCHASE OF COMMUNICATION

4 EQUIPMENT AND INFORMATION TECHNOLOGY.—The 

5 President is authorized to provide, on such terms and con6 ditions as the President may determine, assistance to eligi7 ble developing countries to purchase and maintain the 

8 communications equipment and information technology 

9 described in subsection (b), and the supporting equipment, 

10 necessary to effectively collect, analyze, and transmit pub11 lic health information. 

12 (b) COVERED EQUIPMENT.—The communications 

13 equipment and information technology described in this 

14 subsection are communications equipment and informa15 tion technology that— 

16 (1) are suitable for use under the particular 

17 conditions of the area of intended use; 

18 (2) meet the standards set forth by the World 

19 Health Organization and, as appropriate, the Sec20 retary of Health and Human Services, to ensure 

21 interoperability with like equipment of other coun22 tries and international organizations; and 

23 (3) are not defense articles, defense services, or 

24 training, as those terms are defined in the Arms Ex25 port Control Act (22 U.S.C. 2751 et seq.). 


hmoore on PRODPC68 with HMBILLS
22 

•S 1687 IS

1 (c) RULE OF CONSTRUCTION.—Nothing in this sec2 tion shall be construed to exempt the exporting of goods 

3 and technology from compliance with applicable provisions 

4 of the Export Administration Act of 1979 (as in effect 

5 pursuant to the International Emergency Economic Pow6 ers Act; 50 U.S.C. 1701 et seq.). 

7 (d) LIMITATION.—Amounts appropriated to carry 

8 out this section shall not be made available for the pur9 chase from a foreign country of communications equip10 ment or information technology that, if made in the 

11 United States, would be subject to the Arms Export Con12 trol Act (22 U.S.C. 2751 et seq.) or likely be barred or 

13 subject to special conditions under the Export Administra14 tion Act of 1979 (as in effect pursuant to the Inter15 national Emergency Economic Powers Act; 50 U.S.C. 

16 1701 et seq.). 

17 (e) PROCUREMENT PREFERENCE.—In the use of 

18 grant funds under subsection (a), preference should be 

19 given to the purchase of communications equipment and 

20 information technology of United States manufacture. The 

21 use of amounts appropriated to carry out this section shall 

22 be subject to section 604 of the Foreign Assistance Act 

23 of 1961 (22 U.S.C. 2354). 

24 (f) ASSISTANCE FOR STANDARDIZATION OF REPORT25 ING.—The President is authorized to provide, on such 


hmoore on PRODPC68 with HMBILLS
23 

•S 1687 IS

1 terms and conditions as the President may determine, 

2 technical assistance and grant assistance to international 

3 health organizations to facilitate standardization in the re4 porting of public health information between and among 

5 developing countries and international health organiza6 tions. 

7 (g) COUNTRY COMMITMENTS.—The assistance pro8 vided under this section for communications equipment 

9 and information technology may be provided only if the 

10 eligible developing country that receives such equipment 

11 and technology agrees to provide the infrastructure, tech12 nical personnel, and other resources required to house, 

13 maintain, support, secure, and maximize use of such 

14 equipment and technology. 

15 SEC. 10. ASSIGNMENT OF PUBLIC HEALTH PERSONNEL TO 

16 UNITED STATES MISSIONS AND INTER17 NATIONAL ORGANIZATIONS. 

18 (a) IN GENERAL.—Upon the request of the chief of 

19 a diplomatic mission of the United States or of the head 

20 of an international regional or international health organi21 zation, and with the concurrence of the Secretary and of 

22 the employee concerned, the head of an agency or depart23 ment of the United States may assign to the mission or 

24 the organization any officer or employee of the agency or 

25 department that occupies a public health position within 


hmoore on PRODPC68 with HMBILLS
24 

•S 1687 IS

1 the agency or department for the purpose of enhancing 

2 disease and pathogen surveillance efforts in developing 

3 countries. 

4 (b) REIMBURSEMENT.—The costs incurred by an 

5 agency or department of the United States by reason of 

6 the detail of personnel under subsection (a) may be reim7 bursed to that agency or department out of the applicable 

8 appropriations account of the Department of State if the 

9 Secretary determines that the agency or department may 

10 otherwise be unable to assign such personnel on a non11 reimbursable basis. 

12 SEC. 11. EXPANSION OF CERTAIN UNITED STATES GOVERN13 MENT LABORATORIES ABROAD. 

14 (a) IN GENERAL.—Subject to the availability of ap15 propriations, the Director of the Centers for Disease Con16 trol and Prevention and the Secretary of Defense shall 

17 each— 

18 (1) increase the number of personnel assigned 

19 to laboratories of the Centers for Disease Control 

20 and Prevention or the Department of Defense, as 

21 appropriate, located in eligible developing countries 

22 that conduct research and other activities with re23 spect to infectious diseases; and 

24 (2) expand the operations of such laboratories, 

25 especially with respect to the implementation of onVerDate Aug 31 2005 04:45 Jun 26, 2007 Jkt 059200 PO 00000 Frm 00024 Fmt 6652 Sfmt 6201 E:\BILLS\S1687.IS S1687

hmoore on PRODPC68 with HMBILLS
25 

•S 1687 IS

1 site training of foreign nationals and activities af2 fecting the region in which the country is located. 

3 (b) COOPERATION AND COORDINATION BETWEEN

4 LABORATORIES.—Subsection (a) shall be carried out in 

5 such a manner as to foster cooperation and avoid duplica6 tion between and among laboratories. 

7 (c) RELATION TO CORE MISSIONS AND SECURITY.— 

8 The expansion of the operations of the laboratories of the 

9 Centers for Disease Control and Prevention or the Depart10 ment of Defense located in foreign countries under this 

11 section may not— 

12 (1) detract from the established core missions 

13 of the laboratories; or 

14 (2) compromise the security of those labora15 tories, as well as their research, equipment, exper16 tise, and materials. 

17 SEC. 12. ASSISTANCE FOR INTERNATIONAL HEALTH NET18 WORKS AND EXPANSION OF FIELD EPIDEMI19 OLOGY TRAINING PROGRAMS. 

20 (a) AUTHORITY.—The President is authorized, on 

21 such terms and conditions as the President may deter22 mine, to provide assistance for the purposes of— 

23 (1) enhancing the surveillance and reporting ca24 pabilities for the World Health Organization and exVerDate Aug 31 2005 04:45 Jun 26, 2007 Jkt 059200 PO 00000 Frm 00025 Fmt 6652 Sfmt 6201 E:\BILLS\S1687.IS S1687

hmoore on PRODPC68 with HMBILLS
26 

•S 1687 IS

1 isting international regional and international health 

2 networks; and 

3 (2) developing new international regional and 

4 international health networks. 

5 (b) EXPANSION OF FIELD EPIDEMIOLOGY TRAINING

6 PROGRAMS.—The Secretary of Health and Human Serv7 ices is authorized to establish new country or regional 

8 international Field Epidemiology Training Programs in el9 igible developing countries. 

10 SEC. 13. REPORTS. 

11 Not later than 90 days after the date of enactment 

12 of this Act, the Secretary, in conjunction with the Sec13 retary of Health and Human Services and the Secretary 

14 of Defense, shall submit to the Committee on Foreign Re15 lations of the Senate and the Committee on Foreign Af16 fairs of the House of Representatives a report on the im17 plementation of programs under this Act, including an es18 timate of the level of funding required to carry out such 

19 programs at a sufficient level. 

20 SEC. 14. AUTHORIZATION OF APPROPRIATIONS. 

21 (a) AUTHORIZATION OF APPROPRIATIONS.—Subject 

22 to subsection (c), there are authorized to be appropriated 

23 for the purpose of carrying out activities under this Act 

24 the following amounts: 

25 (1) $40,000,000 for fiscal year 2008. 


hmoore on PRODPC68 with HMBILLS
27 

•S 1687 IS

1 (2) $75,000,000 for fiscal year 2009. 

2 (b) AVAILABILITY OF FUNDS.—The amounts appro3 priated pursuant to subsection (a) are authorized to re4 main available until expended. 

5 (c) LIMITATION ON OBLIGATION OF FUNDS.—Not 

6 more than 10 percent of the amount appropriated pursu7 ant to subsection (a)(1) may be obligated before the date 

8 on which a report is submitted, or required to be sub9 mitted, whichever first occurs, under section 13. 

Æ 


hmoore on PRODPC68 with HMBILLS